Recent cancer diagnostic advances help more cancer patients live longer and better quality lives. Biomarker testing, an advanced diagnostic test, identifies patients eligible for therapies that more precisely and effectively target their tumor cells. As a result, patients experience fewer toxic side effects compared to conventional therapy.
Sunnybrook is a major lung cancer diagnostic centre in Ontario, with testing volumes of about 1,000 lung cancers per year. Currently there are four biomarkers funded by Cancer Care Ontario, but more are known. Sunnybrook hopes to expand to a 50-gene test identifying the mutated genes commonly involved in lung cancer. Expanded testing means the number of patients eligible for precise therapy could increase from 20% to 45%. How impressive is that?
All the proceeds from ‘Crush it with Bev’ supports that effort.
Please donate at Bev’s Fundraising Page and you’ll receive a charitable donation receipt for the full amount.